Navigation Links
ISTA Pharmaceuticals Announces 2011 Guidance and Pipeline Update Webcast/Conference Call on January 5, 2011
Date:12/22/2010

IRVINE, Calif., Dec. 22, 2010 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will conduct a 2011 guidance and pipeline update webcast/conference call after the market closes on January 5, 2011.

President and Chief Executive Officer, Vicente Anido, Jr., Ph.D., and Chief Financial Officer and Vice President of Corporate Development, Lauren Silvernail, will provide 2011 guidance, give a commercial and new product pipeline update, and highlight key milestones for 2011.  The webcast/call will include a slide presentation; participants will be able to view the accompanying slides through ISTA's website.  After the call, the slides will be available for download at http://www.istavision.com/investors.html under "Presentations".Date: Wednesday, January 5, 2011Time: 4:30 p.m. Eastern TimeWebcast and Conference Call Access:Internet: http://www.istavision.com/investors.html Domestic dial-in: 800-299-9086International dial-in: 617-786-2903Passcode: 69989701The webcast/conference call will be webcast live and archived on ISTA's website until February 2, 2011.

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888.  The access code for the replay is 57525060.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals, Inc., is the fourth largest and fastest growing branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics.  ISTA currently markets five products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis.  The Company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain and nasal allergies.  Headquartered in Irvine, California, the Company generated 2009 revenues of $111 million.  For additional information about ISTA Pharmaceuticals, please visit the corporate website at www.istavision.com.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Jazz Pharmaceuticals Announces New Patent Issued for Sodium Oxybate
2. Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA
3. MAP Pharmaceuticals Announces Completion of LEVADEX™ Open-Label Safety Trial
4. Bellicum Pharmaceuticals Announces $3 Million in Convertible Note Funding
5. Lotus Pharmaceuticals Announces Change of Directors
6. Poniard Pharmaceuticals Completes Voluntary Prepayment of Term Loans and Secures New Committed Equity Financing Facility
7. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
8. Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations
9. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
10. John A. MacPhee Resigns From Strativa Pharmaceuticals
11. Poniard Pharmaceuticals Announces Plan for Voluntary Prepayment of Term Loan and Transfer to Nasdaq Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017 ... , and OptiMed Specialty Pharmacy of Kalamazoo, ... offer a strategic hub service that expedites and streamlines ... personal spirometer, Spiro PD 2.0, and wellness management services.  ... is a medical device used to measure lung function ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare ... Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during ... , The annual award competition recognizes editorial and design excellence across a range of ...
Breaking Medicine News(10 mins):